Ambrose Kristen 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 12, 2025
Insider Transaction Report
Form 4
Ambrose Kristen
SVP & Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2025-02-10$467.98/sh−591$276,576→ 11,329 total - Sale
Common Stock
2025-02-11$459.83/sh−1,376$632,726→ 9,953 total
Footnotes (1)
- [F1]Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2024.